Stockscreener 앱 받기
0.3551
4.23%
0.0144
Soligenix Inc 주식(SNGX)의 최신 뉴스
Form 4 Soligenix Inc: Christopher J. Schaber (Director, CHAIRMAN, CEO AND PRESIDENT) For: 12 October - Investing.com Canada
For no payment, director Robert J. Rubin surrendered options on 632 Soligenix (SNGX) shares. - Stock Titan
Diane L. Parks surrenders options on 566 Soligenix (SNGX) shares for no payment. - Stock Titan
Options for 632 shares are surrendered to Soligenix (SNGX) for cancellation without payment. - Stock Titan
Options for 914 shares return to Soligenix (SNGX) for cancellation without payment. - Stock Titan
Soligenix Shareholders Approve Governance and Capital Changes - The Globe and Mail
New Soligenix (SNGX) director options vest through 2027 - Stock Titan
Soligenix (SNGX) director awarded 78,947 stock options - Stock Titan
Soligenix (SNGX) grants director 78,947 stock options at $0.38 - Stock Titan
Soligenix (SNGX) Stock Price, News & Analysis - MarketBeat
Soligenix Inc. (SNGX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Soligenix (SNGX) Earnings Reading: The EPS Result Is Above Expectation in the Latest Session; Share Move - dars.gov.et
Soligenix (SNGX) Earnings Reading: The EPS Result Is Above Expectation in the Latest Session; Share Move - vinanet.vn
Soligenix (SNGX) Financial Results: The EPS Result Is Above Expectation in the Latest Reading; Latest Reaction: Shares Finish 3.79% Lower in the Available RecordRevenue Beat Analysis - vinanet.vn
Soligenix (SNGX) Financial Results: The EPS Result Is Above Expectation in the Latest Reading; Latest Reaction: Shares Finish 3.79% Lower in the Available RecordUpward Estimate Revision - dars.gov.et
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss Provides Marginal BeatAnalyst Coverage Count - vinanet.vn
SNGX Q1 2026 Earnings: Narrower Loss Offers Slight Beat, Yet No Revenue and Stock DipEarnings Trend Analysis - Vinanet
SNGX: Applying for Vaccine Development Funding for Ebola Vaccine - Smartkarma
SNGX: Applying for Vaccine Development Funding for Ebola Vaccine - Yahoo Finance
Soligenix to Present at BIO Investment & Growth Summit (PR Newswire) - Aktiellt
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Share ReactionMid-Term Outlook - vinanet.vn
Soligenix culls topical lymphoma asset after Phase III miss - Yahoo Finance
Soligenix (SNGX) Receives a Buy from Alliance Global Partners - The Globe and Mail
A. G. P. Maintains Soligenix(SNGX.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Soligenix Q2 net loss narrows as R&D expenses fall - TradingView
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results - Barchart.com
SNGX Q1 2026 Earnings: Narrower Loss Provides Modest Upside SurpriseEarnings Beat Streak - vinanet.vn
Soligenix Inc (SNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Soligenix Inc. R (DOA0.MU) stock price, news, quote and history - Yahoo Finance UK
SOLIGENIX, INC. SEC Filing (Aug 3, 2026) - Stock Titan
SNGX Q1 2026 Earnings: Narrow Loss Beat Fails to Move SharesROE Trend Analysis - vinanet.vn
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss in a Revenue-Empty QuarterRevenue Growth Report - vinanet.vn
Soligenix Stock Price Forecast. Should You Buy SNGX? - StockInvest.us
Soligenix Inc (SNGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Soligenix Inc. (SNGX) Q1 2026 Earnings: Narrower Loss Per Share Signals Cost Management, but No Revenue ReportedCEO Earnings Statement - vinanet.vn
Soligenix Inc (SNGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Soligenix Inc (SNGX) Cash Flow - TradingKey
Soligenix Inc (SNGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Soligenix Inc (SNGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Soligenix Inc (SNGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SNGX|Soligenix Inc|Price:0.374|Chg%:-0.001 - tradingkey.com
Soligenix Inc (SNGX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Soligenix Inc (SNGX) Institutional Confidence - TradingKey
Soligenix Inc (SNGX) Income Statement - TradingKey
SNGX|Soligenix Inc|Price:0.400|Chg%:+0.019 - TradingKey
Soligenix, Inc. Revenue Breakdown – NASDAQ:SNGX - TradingView
SNGX Q1 2026 Earnings: EPS Beat Driven by Cost Management Amid No RevenueProfit Margin Analysis - vinanet.vn
SNGX|Soligenix Inc|Price:0.371|Chg%:-0.002 - TradingKey
Soligenix (SNGX) seeks reverse stock split and higher authorized shares - Stock Titan
1.35%
자본화:
|
볼륨(24시간):